Back

Select your region

Corporate

europe:

Flag Albania Albania Flag Bosnia and Herzegovina Bosnia and Herzegovina Flag Bulgaria Bulgaria Flag Croatia Croatia Flag Cyprus Cyprus Flag Montenegro Montenegro Flag Czech Republic Czech Republic Flag Denmark Denmark Flag Estonia Estonia Flag Spain Spain Flag Kosovo Kosovo Flag Lithuania Lithuania Flag Latvia Latvia Flag Luxembourg Luxembourg Flag Macedonia Macedonia Flag Germany Germany Flag Poland Poland Flag Portugal Portugal Flag Romania Romania Flag Serbia Serbia Flag Slovakia Slovakia Flag Slovenia Slovenia Flag Switzerland Switzerland Flag Sweden Sweden Flag Turkey Turkey Flag Hungary Hungary Flag United Kingdom United Kingdom Flag Italy Italy

Asia:

Flag UAE UAE Flag Hong Kong Hong Kong Flag Kuwait Kuwait Flag Lebanon Lebanon

Africa:

Flag South Africa South Africa

Schedule a cord blood consultation

Make an appointment

Contact us today!

Want to learn more about our services? Complete the form below and we will contact you as soon as possible to provide you with all the information you need and answer your questions.

    We kindly inform you that the personal data provided in the form will be processed by Polski Bank Komórek Macierzystych Sp. z o.o. ("PBKM") with its registered office in Warsaw, Al. Jana Pawła II 29 for telephone contact in connection with the provision of information on the service.

    Summary of patients treated

    Stem Cells
    Therapies

    Stem Cells Therapies

    The purpose of banking stem cells is to apply them in the therapy. For the first time cord blood was used in 1988 and since then according to publicly available statistics it has been used over 85 000 times worldwide (including statistics of China).

    FamiCord Group stores over 1,000,000 samples of cells of different types and has supplied stem cells for application in clinic for more than 7000 patients. We supply stem cells for standard transplantations (cord blood , bone marrow and mobilized peripheral blood) and cellular therapies. On top of that we provide cell based products in GMP standard for clinical trials.

    Stem cells manufactured in our premises helped patients with various diseases and therapeutic areas, including haematological, neurological, ophthalmological, orthopaedical, dermatological disorders.

    Check the full list of patients who received stem cell therapy derived from FamiCord labs.

    List last update: 06.2026

    List of patients who received stem cells from FamiCord Group laboratories

    List of patients who received stem cells from FamiCord Group laboratories
    Lp. Source Source type Diagnosis Medical field Year of application Therapy Country Age of recipient
    6401 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 42
    6402 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 60
    6403 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 65
    6404 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 66
    6405 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 66
    6406 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 65
    6407 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 51
    6408 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 69
    6409 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 50
    6410 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 67
    6411 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 50
    6412 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 64
    6413 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 56
    6414 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 74
    6415 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 67
    6416 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 72
    6417 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 59
    6418 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 50
    6419 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 62
    6420 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 68
    6421 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 54
    6422 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 67
    6423 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 22
    6424 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 64
    6425 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 77
    6426 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 66
    6427 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 60
    6428 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 68
    6429 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 39
    6430 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 62
    6431 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 56
    6432 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 63
    6433 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 63
    6434 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 27
    6435 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 70
    6436 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 39
    6437 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 71
    6438 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 32
    6439 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 59
    6440 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 59
    6441 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 63
    6442 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 67
    6443 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 65
    6444 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 66
    6445 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 48
    6446 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 60
    6447 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 57
    6448 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 46
    6449 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 49
    6450 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 4
    6451 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 67
    6452 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 69
    6453 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 63
    6454 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 8
    6455 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 58
    6456 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 61
    6457 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 67
    6458 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Germany 61
    6459 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Germany 65
    6460 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Germany 57
    6461 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Germany 27
    6462 Apheresis Allogeneic Myelodysplastic Syndrome – Raeb Hematology 2018 Standard Therapy Poland 61
    6463 Apheresis Allogeneic Myelodysplastic Syndrome Refractory Anemia With Blast Proliferation Ii Hematology 2018 Standard Therapy Germany 57
    6464 Apheresis Allogeneic Myelodysplastic Syndrome; Acute Lymphoblastic Leukemia Hematology 2018 Standard Therapy Germany 65
    6465 Apheresis Allogeneic Myelodysplastic Syndrome; Acute Myelogenous Leukemia Hematology 2018 Standard Therapy Poland 74
    6466 Apheresis Allogeneic Myelodysplastic Syndrome; Myeloproliferative Neoplasms Hematology 2018 Standard Therapy Germany 62
    6467 Apheresis Allogeneic Myelofibrosis Hematology 2018 Standard Therapy Poland 49
    6468 Apheresis Allogeneic Myelofibrosis Hematology 2018 Standard Therapy Poland 60
    6469 Apheresis Allogeneic Myelofibrosis Hematology 2018 Standard Therapy Poland 56
    6470 Apheresis Allogeneic Myelofibrosis Hematology 2018 Standard Therapy Poland 58
    6471 Apheresis Allogeneic Myelofibrosis Hematology 2018 Standard Therapy Poland 64
    6472 Apheresis Allogeneic Myelofibrosis Hematology 2018 Standard Therapy Poland 68
    6473 Apheresis Allogeneic Myelofibrosis Hematology 2018 Standard Therapy Poland 72
    6474 Apheresis Allogeneic Myelofibrosis Hematology 2018 Standard Therapy Poland 53
    6475 Apheresis Allogeneic Myeloma Multiplex Hematology 2018 Standard Therapy Poland 56
    6476 Apheresis Allogeneic Myeloma Multiplex Hematology 2018 Standard Therapy Poland 57
    6477 Apheresis Allogeneic Myeloma Multiplex Hematology 2018 Standard Therapy Poland 55
    6478 Apheresis Allogeneic Myeloma Multiplex Hematology 2018 Standard Therapy Poland 52
    6479 Apheresis Allogeneic Myeloproliferative Neoplasms Hematology 2018 Standard Therapy Poland 61
    6480 Apheresis Allogeneic No Data Hematology 2018 Standard Therapy Poland 69
    6481 Apheresis Allogeneic No Data Hematology 2018 Standard Therapy Poland 70
    6482 Apheresis Allogeneic No Data Hematology 2018 Standard Therapy Poland 38
    6483 Apheresis Allogeneic No Data Hematology 2018 Standard Therapy Poland 22
    6484 Apheresis Allogeneic No Data Hematology 2018 Standard Therapy Poland 60
    6485 Apheresis Allogeneic No Data Hematology 2018 Standard Therapy Poland 19
    6486 Apheresis Allogeneic No Data Hematology 2018 Standard Therapy Poland 65
    6487 Apheresis Allogeneic No Data Hematology 2018 Standard Therapy Poland 22
    6488 Apheresis Allogeneic No Data Hematology 2018 Standard Therapy Poland 67
    6489 Apheresis Allogeneic No Data Hematology 2018 Standard Therapy Poland 46
    6490 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2018 Standard Therapy Poland 23
    6491 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2018 Standard Therapy Poland 69
    6492 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2018 Standard Therapy Poland 70
    6493 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2018 Standard Therapy Poland 17
    6494 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2018 Standard Therapy Poland 31
    6495 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2018 Standard Therapy Poland 66
    6496 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2018 Standard Therapy Poland 17
    6497 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2018 Standard Therapy Poland 58
    6498 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2018 Standard Therapy Poland 11
    6499 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2018 Standard Therapy Poland 64
    6500 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2018 Standard Therapy Poland 30